Orphan drug designation rules to be largely revised for rapid development
In order to enlarge therapy options for rare or incurable disease patients, regulations about designation of orphan drugs will be modified.
The Ministry of Food and Drug Safety(MFDS) pre-announced the partial revision bill to the ‘Regulations about Designation of Orphan Drugs’ which mainly conta...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
